ITBO2008A000564A
IT1394177B1
(it)
|
2008-09-15 |
2008-09-15 |
Polipeptide fattore ix modificato, sue utilizzazioni e metodo per la sua produzione
|
PL21200005.3T
PL4032979T3
(pl)
|
2008-09-15 |
2009-09-15 |
Mutant polipeptydu czynnika ix, jego zastosowania i sposób jego otrzymywania
|
PCT/EP2009/061935
WO2010029178A1
(en)
|
2008-09-15 |
2009-09-15 |
Factor ix polypeptide mutant, its uses and a method for its production
|
ES09748260.8T
ES2687038T3
(es)
|
2008-09-15 |
2009-09-15 |
Mutante de polipéptido factor IX, sus usos y un método para su producción
|
ES19174517T
ES2940323T3
(es)
|
2008-09-15 |
2009-09-15 |
Mutante de polipéptido factor IX, sus usos y un método para su producción
|
HUE19174517A
HUE061345T2
(hu)
|
2008-09-15 |
2009-09-15 |
IX-es faktor polipeptid mutáns, alkalmazásai és eljárás elõállítására
|
US13/063,898
US9249405B2
(en)
|
2008-09-15 |
2009-09-15 |
Factor IX polypeptide mutant, its uses and a method for its production
|
HRP20230259TT
HRP20230259T1
(hr)
|
2008-09-15 |
2009-09-15 |
Mutant polipeptida faktora ix, njegove primjene i postupak za njegovu proizvodnju
|
EP19174517.3A
EP3581650B1
(en)
|
2008-09-15 |
2009-09-15 |
Factor ix polypeptide mutant, its uses and a method for its production
|
FIEP19174517.3T
FI3581650T3
(fi)
|
2008-09-15 |
2009-09-15 |
IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi
|
PT191745173T
PT3581650T
(pt)
|
2008-09-15 |
2009-09-15 |
Mutante de polipéptido de fator ix, as suas utilizações e um método para a sua produção
|
PL19174517.3T
PL3581650T3
(pl)
|
2008-09-15 |
2009-09-15 |
Zmutowany polipeptyd czynnika ix, jego zastosowania i sposób jego wytwarzania
|
EP09748260.8A
EP2337849B1
(en)
|
2008-09-15 |
2009-09-15 |
Factor ix polypeptide mutant, its uses and a method for its production
|
SI200932179T
SI3581650T1
(sl)
|
2008-09-15 |
2009-09-15 |
Polipeptidni mutant faktorja IX, njegova uporaba in metoda za njegovo proizvodnjo
|
EP17175191.0A
EP3252157A1
(en)
|
2008-09-15 |
2009-09-15 |
Factor ix polypeptide mutant, its uses and a method for its production
|
EP21200005.3A
EP4032979B1
(en)
|
2008-09-15 |
2009-09-15 |
Factor ix polypeptide mutant, its uses and a method for its production
|
EP22214327.3A
EP4219547A3
(en)
|
2008-09-15 |
2009-09-15 |
Factor ix polypeptide mutant, its uses and a method for its production
|
DK19174517.3T
DK3581650T3
(da)
|
2008-09-15 |
2009-09-15 |
Faktor ix polypeptidmutant, anvendelse deraf og en fremgangsmåde til fremstilling deraf
|
DK09748260.8T
DK2337849T3
(en)
|
2008-09-15 |
2009-09-15 |
FACTOR IX POLYPEPTIME MUTANT, APPLICATIONS THEREOF AND METHOD OF PRODUCING THEREOF
|
TR2018/13067T
TR201813067T4
(tr)
|
2008-09-15 |
2009-09-15 |
Faktör IX polipeptit mutantı, bunun kullanımları ve bunu üretmeye yönelik bir yöntem.
|
PL09748260T
PL2337849T3
(pl)
|
2008-09-15 |
2009-09-15 |
Zmutowany polipeptyd czynnika ix, jego zastosowania i sposób jego otrzymywania
|
LTEP19174517.3T
LT3581650T
(lt)
|
2008-09-15 |
2009-09-15 |
Faktoriaus ix polipeptido mutantas, jo panaudojimas ir jo gamybos būdas
|
CA2737094A
CA2737094C
(en)
|
2008-09-15 |
2009-09-15 |
Factor ix polypeptide mutant, its uses and a method for its production
|
US14/981,981
US20160122740A1
(en)
|
2008-09-15 |
2015-12-29 |
Factor ix polypeptide mutant, its uses and method for its production
|
US15/650,070
US9982248B2
(en)
|
2008-09-15 |
2017-07-14 |
Factor IX polypeptide mutant, its uses and method for its production
|
HK18103924.5A
HK1244507A1
(zh)
|
2008-09-15 |
2018-03-21 |
因子ix多肽突變體、其用途及生產方法
|
US15/989,665
US10465180B2
(en)
|
2008-09-15 |
2018-05-25 |
Factor IX polypeptide mutant, its uses and method for its production
|
HRP20181442TT
HRP20181442T1
(hr)
|
2008-09-15 |
2018-09-10 |
Mutant polipeptida faktora ix, njegove koristi i postupak njegove proizvodnje
|
US16/589,851
US20200231958A1
(en)
|
2008-09-15 |
2019-10-01 |
Factor ix polypeptide mutant, its uses and a method for its production
|
US16/707,414
US20200190498A1
(en)
|
2008-09-15 |
2019-12-09 |
Factor ix polypeptide mutant, its uses and a method for its production
|
US16/787,456
US20200199564A1
(en)
|
2008-09-15 |
2020-02-11 |
Factor ix polypeptide mutant, its uses and a method for its production
|
US17/213,897
US20210214704A1
(en)
|
2008-09-15 |
2021-03-26 |
Factor ix polypeptide mutant, its uses and a method for its production
|
US17/213,848
US20210238573A1
(en)
|
2008-09-15 |
2021-03-26 |
Factor ix polypeptide mutant, its uses and a method for its production
|
US17/447,372
US20220002702A1
(en)
|
2008-09-15 |
2021-09-10 |
Factor ix polypeptide mutant, its uses and a method for its production
|
US17/643,326
US20220090042A1
(en)
|
2008-09-15 |
2021-12-08 |
Factor ix polypeptide mutant, its uses and a method for its production
|
CY20231100138T
CY1125885T1
(el)
|
2008-09-15 |
2023-03-14 |
Τροποποιημενο πολυπεπτιδιο παραγοντα ix, οι χρησεις του και μια μεθοδος για την παραγωγη του
|
HUS2300024C
HUS2300024I1
(hu)
|
2008-09-15 |
2023-07-25 |
IX-es faktor polipeptid mutáns, alkalmazásai és eljárás elõállítására
|
FIC20230026C
FIC20230026I1
(fi)
|
2008-09-15 |
2023-07-25 |
Etranakogeenidetsaparvoveekki (adenoassosioitu virusvektori, joka sisältää ihmisen hyytymistekijä IX:n geenin koodonioptimoitua Padua-johdannaista B-hemofilian hoitoon)
|
FR23C1028C
FR23C1028I1
(fr)
|
2008-09-15 |
2023-07-26 |
Mutant de polypeptide du facteur ix, ses utilisations et son procédé de production
|
CY2023016C
CY2023016I2
(el)
|
2008-09-15 |
2023-07-27 |
Τροποποιημενο πολυπεπτιδιο παραγοντα ix, οι χρησεις του και μια μεθοδος για την παραγωγη του
|
LTPA2023521C
LTPA2023521I1
(it)
|
2008-09-15 |
2023-07-27 |
|
NO2023029C
NO2023029I1
(no)
|
2008-09-15 |
2023-07-31 |
Etranacogene dezaparvovec (an adeno-associated viral vector containing a codon-optimized Padua derivative of human coagulation factor IX gene)
|